{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:00:19Z","timestamp":1791414019864,"version":"4.3.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1177\/1933719115607994","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:49:50Z","timestamp":1443660590000},"page":"302-309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Proteoglycans in Leiomyoma and Normal Myometrium: bundance, Steroid Hormone Control, and Implications for Pathophysiology"],"prefix":"10.1007","volume":"23","author":[{"given":"Nichole M.","family":"Barker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Carrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold I.","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Hurd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Mesiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"issue":"4","key":"23030302_CR1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ajog.2006.02.020","volume":"195","author":"M Flynn","year":"2006","unstructured":"Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195(4):955\u2013964.","journal-title":"Am J Obstet Gynecol."},{"issue":"3","key":"23030302_CR2","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211.e1\u20139.","journal-title":"Am J Obstet Gynecol."},{"issue":"5","key":"23030302_CR3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","volume":"73","author":"A Arici","year":"2000","unstructured":"Arici A, Sozen I. Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril. 2000;73(5): 1006\u20131011.","journal-title":"Fertil Steril."},{"issue":"4","key":"23030302_CR4","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/humrep\/deh698","volume":"20","author":"AA Arslan","year":"2005","unstructured":"Arslan AA, Gold LI, Mittal K, et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod. 2005;20(4): 852\u2013863.","journal-title":"Hum Reprod."},{"issue":"2","key":"23030302_CR5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","volume":"195","author":"PC Leppert","year":"2006","unstructured":"Leppert PC, Catherino WH, Segars JH. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol. 2006;195(2):415\u2013420.","journal-title":"Am J Obstet Gynecol."},{"issue":"3","key":"23030302_CR6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0030-1251475","volume":"28","author":"M Malik","year":"2010","unstructured":"Malik M, Norian J, McCarthy-Keith D, Britten J, Catherino WH. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin Reprod Med. 2010; 28(3):169\u2013179.","journal-title":"Semin Reprod Med."},{"issue":"1","key":"23030302_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)03154-0","volume":"78","author":"I Sozen","year":"2002","unstructured":"Sozen I, Arici A. Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril. 2002;78(1):1\u201312.","journal-title":"Fertil Steril."},{"issue":"3","key":"23030302_CR8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1083\/jcb.136.3.729","volume":"136","author":"KG Danielson","year":"1997","unstructured":"Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 1997; 136(3):729\u2013743.","journal-title":"J Cell Biol."},{"issue":"6281","key":"23030302_CR9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/346281a0","volume":"346","author":"Y Yamaguchi","year":"1990","unstructured":"Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990;346(6281):281\u2013284.","journal-title":"Nature"},{"issue":"11","key":"23030302_CR10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0006-2952(97)00343-2","volume":"54","author":"SN Giri","year":"1997","unstructured":"Giri SN, Hyde DM, Braun RK, Gaarde W, Harper JR, Pierschbacher MD. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol. 1997;54(11): 1205\u20131216.","journal-title":"Biochem Pharmacol."},{"issue":"6","key":"23030302_CR11","doi-asserted-by":"crossref","first-page":"L1327","DOI":"10.1152\/ajplung.2001.280.6.L1327","volume":"280","author":"M Kolb","year":"2001","unstructured":"Kolb M, Margetts PJ, Sime PJ, Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol. 2001; 280(6): L1327\u20131334.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"issue":"4","key":"23030302_CR12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1743-6109.2006.00150.x","volume":"14","author":"H Jarvelainen","year":"2006","unstructured":"Jarvelainen H, Puolakkainen P, Pakkanen S, et al. A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen. 2006;14(4):443\u2013452.","journal-title":"Wound Repair Regen."},{"issue":"18","key":"23030302_CR13","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med. 2000; 342(18):1350\u20131358.","journal-title":"N Engl J Med."},{"issue":"2","key":"23030302_CR14","first-page":"913","volume":"86","author":"BS Lee","year":"2001","unstructured":"Lee BS, Nowak RA. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. J Clin Endocrinol Metab. 2001;86(2):913\u2013920.","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"23030302_CR15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","volume":"16","author":"JM Norian","year":"2009","unstructured":"Norian JM, Malik M, Parker CY, et al. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod Sci. 2009;16(12): 1153\u20131164.","journal-title":"Reprod Sci."},{"issue":"1","key":"23030302_CR16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ar.20797","volume":"292","author":"RM Salgado","year":"2009","unstructured":"Salgado RM, Favaro RR, Martin SS, Zorn TM. The estrous cycle modulates small leucine-rich proteoglycans expression in mouse uterine tissues. Anat Rec (Hoboken). 2009;292(1):138\u2013153.","journal-title":"Anat Rec (Hoboken)"},{"issue":"2","key":"23030302_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2004-828616","volume":"22","author":"JD Cook","year":"2004","unstructured":"Cook JD, Walker CL. Treatment strategies for uterine leiomyoma: the role of hormonal modulation. Semin Reprod Med. 2004;22(2):105\u2013111.","journal-title":"Semin Reprod Med."},{"issue":"5728","key":"23030302_CR18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","volume":"308","author":"CL Walker","year":"2005","unstructured":"Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(5728):1589\u20131592.","journal-title":"Science."},{"issue":"2","key":"23030302_CR19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9378(16)33500-1","volume":"122","author":"RW Noyes","year":"1975","unstructured":"Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975;122(2):262\u2013263.","journal-title":"Am J Obstet Gynecol."},{"issue":"6","key":"23030302_CR20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.LAB.0000017499.51216.3E","volume":"82","author":"SA Carney","year":"2002","unstructured":"Carney SA, Tahara H, Swartz CD, et al. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest. 2002;82(6):719\u2013728.","journal-title":"Lab Invest."},{"issue":"2","key":"23030302_CR21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1095\/biolreprod67.2.506","volume":"67","author":"J Condon","year":"2002","unstructured":"Condon J, Yin S, Mayhew B, et al. Telomerase immortalization of human myometrial cells. Biol Reprod. 2002;67(2):506\u2013514.","journal-title":"Biol Reprod."},{"issue":"2","key":"23030302_CR22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/BJ20111996","volume":"443","author":"DA Carrino","year":"2012","unstructured":"Carrino DA, Mesiano S, Barker NM, Hurd WW, Caplan AI. Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition. Biochem J. 2012;443(2):361\u2013368.","journal-title":"Biochem J."},{"issue":"3","key":"23030302_CR23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/gcc.20035","volume":"40","author":"WH Catherino","year":"2004","unstructured":"Catherino WH, Leppert PC, Stenmark MH, et al. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer. 2004;40(3): 204\u2013217.","journal-title":"Genes Chromosomes Cancer."},{"issue":"3","key":"23030302_CR24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.fertnstert.2006.10.001","volume":"87","author":"TM Roth","year":"2007","unstructured":"Roth TM, Klett C, Cowan BD. Expression profile of several genes in human myometrium and uterine leiomyoma. Fertil Steril. 2007;87(3):635\u2013641.","journal-title":"Fertil Steril."},{"issue":"2","key":"23030302_CR25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10735-012-9476-1","volume":"44","author":"RM Salgado","year":"2013","unstructured":"Salgado RM, Covarrubias AC, Favaro RR, Serrano-Nascimento C, Nunes MT, Zorn TM. Estradiol induces transcriptional and posttranscriptional modifications in versican expression in the mouse uterus. J Mol Histol. 2013;44(2):221\u2013229.","journal-title":"J Mol Histol."},{"issue":"50","key":"23030302_CR26","doi-asserted-by":"crossref","first-page":"39027","DOI":"10.1074\/jbc.M006700200","volume":"275","author":"N Verzijl","year":"2000","unstructured":"Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000;275(50):39027\u201339031.","journal-title":"J Biol Chem."},{"issue":"3","key":"23030302_CR27","first-page":"900","volume":"79","author":"EA Stewart","year":"1994","unstructured":"Stewart EA, Friedman AJ, Peck K, Nowak RA. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab. 1994; 79(3):900\u2013906.","journal-title":"J Clin Endocrinol Metab."},{"issue":"10\u201313","key":"23030302_CR28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.steroids.2003.09.008","volume":"68","author":"D DeManno","year":"2003","unstructured":"DeManno D, Elger W, Garg R, et al. Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy. Steroids. 2003;68(10\u201313):1019\u20131032.","journal-title":"Steroids."},{"issue":"4","key":"23030302_CR29","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2005-2379","volume":"91","author":"W Chen","year":"2006","unstructured":"Chen W, Ohara N, Wang J, et al. A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. J Clin Endocrinol Metab. 2006;91(4):1296\u20131304.","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"23030302_CR30","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/humrep\/del035","volume":"21","author":"J Wang","year":"2006","unstructured":"Wang J, Ohara N, Wang Z, et al. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells. Hum Reprod. 2006;21(7):1869\u20131877.","journal-title":"Hum Reprod."},{"issue":"4","key":"23030302_CR31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/09513590701350416","volume":"23","author":"T Maruo","year":"2007","unstructured":"Maruo T. Progesterone and progesterone receptor modulator in uterine leiomyoma growth. Gynecol Endocrinol. 2007;23(4): 186\u2013187.","journal-title":"Gynecol Endocrinol."},{"issue":"2","key":"23030302_CR32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1210\/jc.2006-0898","volume":"92","author":"H Sasaki","year":"2007","unstructured":"Sasaki H, Ohara N, Xu Q, et al. A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. J Clin Endocrinol Metab. 2007;92(2):616\u2013623.","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"23030302_CR33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","volume":"111","author":"ED Levens","year":"2008","unstructured":"Levens ED, Potlog-Nahari C, Armstrong AY, et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol. 2008;111(5):1129\u20131136.","journal-title":"Obstet Gynecol."},{"issue":"4","key":"23030302_CR34","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/humrep\/den025","volume":"23","author":"A Morikawa","year":"2008","unstructured":"Morikawa A, Ohara N, Xu Q, et al. Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer. Hum Reprod. 2008;23(4):944\u2013951.","journal-title":"Hum Reprod."},{"issue":"3","key":"23030302_CR35","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0030-1251483","volume":"28","author":"S Yoshida","year":"2010","unstructured":"Yoshida S, Ohara N, Xu Q, et al. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Semin Reprod Med. 2010;28(3): 260\u2013273.","journal-title":"Semin Reprod Med."},{"key":"23030302_CR36","doi-asserted-by":"crossref","unstructured":"Nieman LK, Blocker W, Nansel T, et al. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study. Fertil Steril. 2011;95(2):767-772.e1-2.","DOI":"10.1016\/j.fertnstert.2010.09.059"},{"issue":"5","key":"23030302_CR37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","volume":"366","author":"J Donnez","year":"2012","unstructured":"Donnez J, Tomaszewski J, Vazquez F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012; 366(5):421\u2013432.","journal-title":"N Engl J Med."},{"issue":"8","key":"23030302_CR38","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12325-012-0042-8","volume":"29","author":"VS Talaulikar","year":"2012","unstructured":"Talaulikar VS, Manyonda IT. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids. Adv Ther. 2012;29(8):655\u2013663.","journal-title":"Adv Ther."},{"key":"23030302_CR39","first-page":"285","volume":"8","author":"N Biglia","year":"2014","unstructured":"Biglia N, Carinelli S, Maiorana A, D\u2019Alonzo M, Lo Monte G, Marci R. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids. Drug Des Devel Ther. 2014;8: 285\u2013292.","journal-title":"Drug Des Devel Ther."},{"issue":"6","key":"23030302_CR40","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","volume":"101","author":"J Donnez","year":"2014","unstructured":"Donnez J, Vazquez F, Tomaszewski J, et al. Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril. 2014; 101(6):1565\u20131573.e1-8.","journal-title":"Fertil Steril."}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719115607994.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719115607994","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719115607994\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719115607994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719115607994.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:43:15Z","timestamp":1656812595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719115607994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["23030302"],"URL":"https:\/\/doi.org\/10.1177\/1933719115607994","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"1 March 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}